T. Iwanaga

Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma

Kazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi et al. · Liver Cancer · 2021 · 52 citations · Full text

Medicine, Oncology, Pharmacology +14

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Keisuke Koroki, Naoya Kanogawa, Susumu Maruta et al. · Liver Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells

Junjie Ao, Tetsuhiro Chiba, Shuhei Shibata et al. · Biochemical and Biophysical Research Communications · 2021 · 31 citations

Medicine, Cancer Biology, Oncology +16

Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice

Miyuki Nakagawa, Masanori Inoue, Sadahisa Ogasawara et al. · Cancer · 2022 · 27 citations

Medicine, Oncology, Pharmacology +15

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment

Shohei Mukai, Hiroaki Kanzaki, Sadahisa Ogasawara et al. · JGH Open · 2021 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +17